$WST News

West (WST) Stock Looks Overvalued After A 47% One Year Run

Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2

West Pharmaceutical Services (WST) Price Target Increased by 11.46% to 405.03

Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $412

Is Stronger Q2 Results, Raised Outlook and Buybacks Altering The Investment Case For West Pharmaceutical Services (WST)?

West Pharmaceutical Services (WST) Raised Guidance, Is The Upside Already Priced In?

The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call

3 Reasons to Avoid WST and 1 Stock to Buy Instead

Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $425

West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan

WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook

West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift

West Pharmaceutical Services Q2 Earnings Call Highlights

West Pharmaceutical Services, Inc. 2026 Q2 - Results - Earnings Call Presentation

West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Highlights: Strong Organic Growth ...

West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars

West Pharmaceutical Services, Inc. (WST) Q2 2026 Earnings Call Transcript

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum

West Pharmaceutical Services Q2 Adjusted Earnings, Net Sales Rise; 2026 Outlook Boosted